Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000609191 | SCV000718600 | likely benign | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000609191 | SCV002454114 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331041 | SCV002630442 | likely benign | Cardiovascular phenotype | 2019-05-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003758877 | SCV004564232 | likely benign | Cardiomyopathy, familial hypertrophic 27 | 2022-12-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530771 | SCV004739001 | likely benign | ALPK3-related disorder | 2019-05-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001701055 | SCV001921789 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000609191 | SCV001972227 | likely benign | not provided | no assertion criteria provided | clinical testing |